ReviewMolecular biology reports2026
The synergistic applications of organoids and exosomes in disease modeling and disease treatment.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Versatile Roles of Exosomes in Neurodegenerative Disorders: From Pathological Mechanism and Diagnostic Biomarkers to Therapeutic Application.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a three-dimensional miniature organ model, organoids can simulate the structural and functional heterogeneity of the tissues, especially demonstrating unique advantages in disease pathogenesis and personalized drug screening. Exosomes are key carriers of intercellular communication, carrying small biological molecules (proteins and nucleic acids), and exhibit the significant potential in disease diagnosis, signal transduction, and targeted therapy. However, both of them have certain limitations in terms of applications. The synergistic applications of organoids and exosomes can achieve complementary functions and information carriers between them, which may become a potential strategy to promote the elucidation of disease mechanisms, drug screening, and the clinical translation. In this review, we summarize the cultivation and isolation methods of organoids and exosomes, and introduce the synergistic applications of organoid and exosomes in disease modeling, mechanism research, diagnostic biomarker discovery, and treatment strategy development in different types of diseases. This review will establish a foundation for theoretical basis and technical reference for precision medicine and regenerative medicine.
Indexed as
Identifiers
42133100What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.